These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 14612526)
1. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Kim MS; Blake M; Baek JH; Kohlhagen G; Pommier Y; Carrier F Cancer Res; 2003 Nov; 63(21):7291-300. PubMed ID: 14612526 [TBL] [Abstract][Full Text] [Related]
2. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid. Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382 [TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta. Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310 [TBL] [Abstract][Full Text] [Related]
5. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). Kim MS; Baek JH; Chakravarty D; Sidransky D; Carrier F Exp Cell Res; 2005 May; 306(1):94-102. PubMed ID: 15878336 [TBL] [Abstract][Full Text] [Related]
6. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells. El-Khoury V; Gomez D; Liautaud-Roger F; Trussardi-Régnier A; Dufer J Cytometry A; 2004 Dec; 62(2):109-17. PubMed ID: 15517561 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide. Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797 [TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692 [TBL] [Abstract][Full Text] [Related]
9. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. Wang ZM; Hu J; Zhou D; Xu ZY; Panasci LC; Chen ZP Ai Zheng; 2002 Oct; 21(10):1100-5. PubMed ID: 12508652 [TBL] [Abstract][Full Text] [Related]
10. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age. Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955 [TBL] [Abstract][Full Text] [Related]
11. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients. Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. Khaw AK; Silasudjana M; Banerjee B; Suzuki M; Baskar R; Hande MP Mutat Res; 2007 Dec; 625(1-2):134-44. PubMed ID: 17669439 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. Dong G; Wang L; Wang CY; Yang T; Kumar MV; Dong Z J Pharmacol Exp Ther; 2008 Jun; 325(3):978-84. PubMed ID: 18310471 [TBL] [Abstract][Full Text] [Related]
16. Complex response of breast epithelial cell lines to topoisomerase inhibitors. Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486 [TBL] [Abstract][Full Text] [Related]
17. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. Chen J; Du C; Kang J; Wang J Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528 [TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. Law AY; Lai KP; Lui WC; Wan HT; Wong CK Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825 [TBL] [Abstract][Full Text] [Related]
19. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications. Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079 [TBL] [Abstract][Full Text] [Related]
20. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo. Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]